PPT-MDR/XDR Tuberculosis and Atypical

Mycobacterial Disease Increasing Role for Surgery Relearning Old Lessons John D Mitchell MD Professor and Chief Section of General Thoracic Surgery Davis Endowed Chair in Thoracic Surgery. Government stewardship and accountability with monitoring and evaluation 2 Strong coalition with civil society organizations and communities 3 Protection and promotion of human rights ethics and equity 4 Adaptation of the strategy and targets at cou David . Bryden. | RESULTS TB Advocacy Officer | 2015. Mandy . Slutsker. | ACTION Senior Associate on TB and the Global Fund | 2015. 9.6 million new TB cases; 480,000 were . MDR-TB.. Nearly . 2 out of every 5 cases (37%) of TB are either undiagnosed or unreported. . Bruce A. Bush, M.D.. Regional Tuberculosis Consultant. Pennsylvania Department of Health. Senior Vice President for Medical Affairs. Indiana Regional Medical Center. Disclosures. I do not have any financial arrangements or affiliations with a commercial entity.. F. uture . of TB . Therapy. Putting science to work for better, faster TB cures. Achieving maximum impact will require:. Short, simple regimens that are adopted, available and affordable.. Ideally, a universal regimen consisting of all novel drugs that is effective in all people with active TB. . Disseminate recommendations to each Division Officer/LCPO. W/C Supervisor identify personnel meeting criteria. W/C personnel schedule exam with Occupational Health clinic or supporting MDR. W/C personnel go to exam appointment(s) and inform Div chain of command when complete. Mekong . Sub-region. CAP-TB PROJECT. . Strengthening the health system through basic building blocks for TB control . CAP-TB Strategic Model. Integration with the health system for TB control and prevention. Naira Dekhil. 1. , . Besma. Mhenni. 1. , Raja Haltiti. 2. , and . Helmi. Mardassi. 1. . (speaker).  . 1. Unit of Typing & Genetics of . Mycobacteria. , . Institut. Pasteur de Tunis, . Tunisia. MMed. (. Fam. Med) (MED). Director, . Drug-Resistant TB, TB & HIV . Models of Care for People with Drug-Resistant TB: Advancements in South Africa. Background and TB burden in South Africa. Models . , Senior Medical Officer at Helen Joseph Hospital . Shorter, Simpler Treatment for XDR-TB . One day . of XDR treatment today . Treatment duration: 2+ years. One week . of BPaL regimen in Nix-TB trial. ries 14 61 contributed data on 17690 isolates whichThese drugs are more costly toxic and less effective thanfirst-line drugs used for routine treatment of TB with other diseases resistance to TB drugs tuberculosis in high-burden countries. Kathrin . Zürcher. , Marie . Ballif. , Lukas . Fenner. , Sonia . Borrell. , Peter M. Keller, Joachim . Gnokoro. , Olivier Marcy, Marcel . Yotebieng. , . Lameck. Dr.. . Mohed. Shaker. A Brief History of Tuberculosis (TB). Tuberculosis (phthisis) described since the time of . Hippocrates (460 BC - 370 BC). . 1689: Doctor Richard Morton . used the term . “consumption”. Álvarez-Narváez S, Giguère S, Cohen N, Slovis N, Vázquez-Boland JA. Spread of Multidrug-Resistant Rhodococcus equi, United States. Emerg Infect Dis. 2021;27(2):529-537. https://doi.org/10.3201/eid2702.203030. The treatment of drug-susceptible. and drug-resistant tuberculosis. Antwerp, 11 April 2019. Hans L Rieder. Efficacy, effectiveness, efficiency…. Efficacy. What can the drug do? (ideal conditions, simulated in clinical trial settings: factually evaluating .